Human immune cells infiltrate the spinal cord and impair recovery after spinal cord injury in humanized mice.
Randall S CarpenterRoselyn R JiangFaith H BrennanJodie C E HallManoj K GottipatiStefan NiewieskPhillip G PopovichPublished in: Scientific reports (2019)
Humanized mice can be used to better understand how the human immune system responds to central nervous system (CNS) injury and inflammation. The optimal parameters for using humanized mice in preclinical CNS injury models need to be established for appropriate use and interpretation. Here, we show that the developmental age of the human immune system significantly affects anatomical and functional outcome measures in a preclinical model of traumatic spinal cord injury (SCI). Specifically, it takes approximately 3-4 months for a stable and functionally competent human immune system to develop in neonatal immune compromised mice after they are engrafted with human umbilical cord blood stem cells. Humanized mice receiving a SCI before or after stable engraftment exhibit significantly different neuroinflammatory profiles. Importantly, the development of a mature human immune system was associated with worse lesion pathology and neurological recovery after SCI. In these mice, human T cells infiltrate the spinal cord lesion and directly contact human macrophages. Together, data in this report establish an optimal experimental framework for using humanized mice to help translate promising preclinical therapies for CNS injury.
Keyphrases
- spinal cord injury
- endothelial cells
- spinal cord
- stem cells
- induced pluripotent stem cells
- high fat diet induced
- pluripotent stem cells
- oxidative stress
- neuropathic pain
- metabolic syndrome
- machine learning
- blood brain barrier
- mesenchymal stem cells
- brain injury
- cell therapy
- skeletal muscle
- big data
- monoclonal antibody
- insulin resistance
- artificial intelligence